We are monitoring the impact of COVID-19 on APAC Enteral Feeding Formulas Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3202
Share on
Share on

Asia Pacific Enteral Feeding Formulas Market Research Report - Segmented By Product, Stage, Application, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 3202
Pages: 138

APAC Enteral Feeding Formulas Market Size (2021 to 2026)

As per the research report, the Asia Pacific Enteral Feeding Devices Market size has been estimated at USD 1.01 Billion in 2021. It is further estimated to be growing at a CAGR of 8.9% and worth USD 1.55 billion by 2026. The market for enteral feeding formulae has grown significantly in recent years, which has had a beneficial impact on the market's overall growth.

An expanding population of geriatrics, more premature births, growing use of enteral nutrition, and a more considerable prevalence of chronic diseases are primarily contributing to the rise of the enteral feeding formulas market in the Asia Pacific. One of the other vital aspects is that enteral nutrition is less expensive than parenteral nutrition. The average daily cost of enteral nutrition for a patient is around 40% less than that of parenteral nutrition. Because of these advantages, enteral feeding is now widely used in various treatment regimens. Furthermore, enteral feeding supplies artificial nutrition or medication to the organs via the gastrointestinal tract, including the esophagus, stomach, and small and large intestine.

The rising frequencies of chronic diseases and disorders, quickly growing senior population, rising healthcare cost, rising prevalence of preterm births, and increasing demand for home care are also expected to drive the Asia Pacific enteral feeding formulas market.

However, factors such as enteral nutrition issues, patient safety risks, and the frequency of feeding and medication errors are projected to limit the growth of the enteral feeding formulas market to some extent in this region. Enteral nutrition is a time- and money-saving method of giving therapeutic nutrition to patients. However, there are a few drawbacks to using these devices, which result in higher healthcare expenses.

This research report on the Asia-Pacific enteral feeding formulas market has been segmented and sub-segmented into the following categories:

By Product: 

  • Polymeric
  • Monomeric
  • Disease-Specific Formulas

By Stage: 

  • Adults
  • Pediatrics

By Application: 

  • Oncology
  • Gastroenterology
  • Neurology

By End User: 

  • Hospitals
  • LTCS
  • Home Care

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The Asia Pacific region is likely to provide substantial growth possibilities for market competitors during the forecast period. This is due to the region's diverse healthcare markets, increased R&D initiatives to produce breakthrough medical technology, and the rising incidence of infectious and chronic diseases. Furthermore, infrastructural advances in healthcare facilities, rising healthcare expenditure, and growing APAC countries' low-cost manufacturing advantage are projected to entice market participants to invest in the region in the upcoming years. In addition, the region's increasing burden of chronic diseases and the elderly population is predicted to increase demand for enteral feeding systems to meet the nutritional needs of people who can't eat or digest food.

A mature and well-structured healthcare system exists in Asia-Pacific, particularly in China and India. The region is a center for research and development operations, and its policies and investment support attract significant businesses to build their headquarters there. As a result, these countries have a plethora of market participants.

The Asia-Pacific region is predicted to become the growth center for the enteral feeding formulae market, with China, India, and Japan growing at a substantial rate due to rising elderly populations and the increasing prevalence of chronic diseases and disorders.

KEY MARKET PLAYERS:

Some of the most promising companies leading in the APAC Enteral Feeding Formulas Market profiled in the report are Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).

1.Introduction            

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods    

                1.4 General Study Assumptions                

2. Research Methodology                     

                2.1 Introduction         

                2.2 Research Phases

          2.2.1 Secondary Research           

          2.2.2 Primary Research 

          2.2.3 Econometric Modelling      

          2.2.4 Expert Validation  

                2.3 Analysis Design   

                2.4 Study Timeline    

3. Overview                 

                3.1 Executive Summary                

                3.2 Key Inferences   

                3.3 Epidemology        

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)              

                4.1 Market Drivers    

                4.2 Market Restraints                    

                4.3 Key Challenges   

                4.4 Current Opportunities in the Market        

5. Market Segmentation  

                5.1 Product  

          5.1.1 Polymeric

          5.1.2 Monomeric             

          5.1.3 Disease-Specific Formulas

          5.1.4  Y-o-Y Growth Analysis, By Product              

          5.1.5  Market Attractiveness Analysis, By Product            

          5.1.6  Market Share Analysis, By Product              

                5.2 Stage       

          5.2.1 Adults       

          5.2.2 Pediatrics 

          5.2.3 Y-o-Y Growth Analysis, By Stage    

          5.2.4 Market Attractiveness Analysis, By Stage  

          5.2.5 Market Share Analysis, By Stage    

                5.3 Application                 

          5.3.1 Oncology 

          5.3.2 Gastroenterology

          5.3.3 Neurology               

          5.3.4 Y-o-Y Growth Analysis, By Application         

          5.3.5  Market Attractiveness Analysis, By Application      

          5.3.6  Market Share Analysis, By Application       

                5.4 End Users                    

          5.4.1 Hospitals  

          5.4.2 LTCS           

          5.4.3 Home Care              

          5.4.4 Y-o-Y Growth Analysis, By End Users           

          5.4.5  Market Attractiveness Analysis, By End Users        

          5.4.6  Market Share Analysis, By End Users          

6. Geographical Analysis  

                6.1 Introduction         

          6.1.1 Regional Trends    

          6.1.2 Impact Analysis     

          6.1.3 Y-o-Y Growth Analysis        

    6.1.3.1 By Geographical Area

    6.1.3.2 By Product

    6.1.3.3 By Type

    6.1.3.4 By Application

    6.1.3.5 By End Users

          6.1.4  Market Attractiveness Analysis     

    6.1.4.1 By Geographical Area

    6.1.4.2 By Product

    6.1.4.3 By Stage

    6.1.4.4 By Application

    6.1.4.5 By End Users

          6.1.5  Market Share Analysis      

    6.1.5.1 By Geographical Area

    6.1.5.2 By Product

    6.1.5.3 By Stage

    6.1.5.4 By Application

    6.1.5.5 By End Users

                6.2 China       

                6.3 India        

                6.4 Japan      

                6.5 South Korea         

                6.6 Australia

7.Strategic Analysis                  

                7.1 PESTLE analysis   

          7.1.1 Political     

          7.1.2 Economic 

          7.1.3 Social         

          7.1.4 Technological         

          7.1.5 Legal          

          7.1.6 Environmental       

                7.2 Porter’s Five analysis        

          7.2.1 Bargaining Power of Suppliers        

          7.2.2 Bargaining Power of Consumers    

          7.2.3 Threat of New Entrants     

          7.2.4 Threat of Substitute Products and Services              

          7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                   

                8.1 Abbott Laboratories         

          8.1.1 Overview 

          8.1.2 Product Analysis   

          8.1.3 Financial analysis  

          8.1.4 Recent Developments       

          8.1.5 SWOT analysis       

          8.1.6 Analyst View          

                8.2 Nestle S.A.                  

                8.3 Danone S.A.         

                8.4 Fresenius Kabi AG                   

                8.5 Mead Johnson Nutrition Company                  

                8.6 B. Braun Melsungen AG  

                8.7 Hormel Foods      

                8.8 LLC                 

                8.9 Victus Inc.                   

                8.10 Meiji Holdings Co. Ltd.   

                8.11 Global health Product Inc.                 

9.Competitive Landscape

                9.1 Market share analysis      

                9.2 Merger and Acquisition Analysis 

                9.3 Agreements, collaborations and Joint Ventures   

                9.4 New Product Launches   

10.Market Outlook and Investment Opportunities                    

Appendix                     

                a) List of Tables                

                b) List of Figures        

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Enteral Feeding Formulas Market, By Product, From 2021 to 2026 (USD Billion)
  2. Asia-Pacific Polymeric Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia-Pacific Monomeric Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia-Pacific Disease-Specific Formulas Market, By Region, From 2021 to 2026 (USD Billion)
  5. Asia-Pacific Enteral Feeding Formulas Market, By Stage, From 2021 to 2026 (USD Billion)
  6. Asia-Pacific Adults Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia-Pacific Pediatrics Market, By Region, From 2021 to 2026 (USD Billion)
  8. Asia-Pacific Enteral Feeding Formulas Market, By Application, From 2021 to 2026 (USD Billion)
  9. Asia-Pacific Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  10. Asia-Pacific Gastroenterology Market, By Region, From 2021 to 2026 (USD Billion)
  11. Asia-Pacific Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  12. Asia-Pacific Enteral Feeding Formulas Market, By End User, From 2021 to 2026 (USD Billion)
  13. Asia-Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  14. Asia-Pacific LTCS Market, By Region, From 2021 to 2026 (USD Billion)
  15. Asia-Pacific Home Care Market, By Region, From 2021 to 2026 (USD Billion)
  16. Japan Enteral Feeding Formulas Market, By Product, From 2021 to 2026 (USD Billion)
  17. Japan Enteral Feeding Formulas Market, By Stage, From 2021 to 2026 (USD Billion)
  18. Japan Enteral Feeding Formulas Market, By Application, From 2021 to 2026 (USD Billion)
  19. Japan Enteral Feeding Formulas Market, By End User, From 2021 to 2026 (USD Billion)
  20. China Enteral Feeding Formulas Market, By Product, From 2021 to 2026 (USD Billion)
  21. China Enteral Feeding Formulas Market, By Stage, From 2021 to 2026 (USD Billion)
  22. China Enteral Feeding Formulas Market, By Application, From 2021 to 2026 (USD Billion)
  23. China Enteral Feeding Formulas Market, By End User, From 2021 to 2026 (USD Billion)
  24. India Enteral Feeding Formulas Market, By Product, From 2021 to 2026 (USD Billion)
  25. India Enteral Feeding Formulas Market, By Stage, From 2021 to 2026 (USD Billion)
  26. India Enteral Feeding Formulas Market, By Application, From 2021 to 2026 (USD Billion)
  27. India Enteral Feeding Formulas Market, By End User, From 2021 to 2026 (USD Billion)
  28. Australia Enteral Feeding Formulas Market, By Product, From 2021 to 2026 (USD Billion)
  29. Australia Enteral Feeding Formulas Market, By Stage, From 2021 to 2026 (USD Billion)
  30. Australia Enteral Feeding Formulas Market, By Application, From 2021 to 2026 (USD Billion)
  31. Australia Enteral Feeding Formulas Market, By End User, From 2021 to 2026 (USD Billion)
  32. South Korea Enteral Feeding Formulas Market, By Product, From 2021 to 2026 (USD Billion)
  33. South Korea Enteral Feeding Formulas Market, By Stage, From 2021 to 2026 (USD Billion)
  34. South Korea Enteral Feeding Formulas Market, By Application, From 2021 to 2026 (USD Billion)
  35. South Korea Enteral Feeding Formulas Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample